AMGN acquires HZNP for $116.50/sh cash—a 48% premium to HZNP’s “unaffected” closing price on 11/29/22: https://finance.yahoo.com/news/1-amgen-set-buy-biotech-084931579.html The nominal deal value (including assumed debt) is $28.3B.